stars 1 stars 2 stars 3

ProSolus Pharmaceuticals delivers sophisticated transdermal solutions customized to meet your needs and exceed your expectations. We formulate, develop, and manufacture high-barrier-to-entry transdermal drug delivery products in our state-of-the-art laboratories and manufacturing facility. Our patches are designed with the patient in mind. ProSolus Pharmaceuticals is an experienced partner with unrivaled transdermal prowess. Our experts are committed to delivering a customized experience every step of the way concept through completion. Whether you need formulation, development, and/or manufacturing support, we’ll provide sophisticated solutions tailored to your needs. Our research and development team works collaboratively with strategic suppliers to create polymers and design combinations of excipients that improve the absorption of medications through the skin without having to resort to exotic permeation enhancers. Focused on what lies ahead, our team continues to explore methods to optimize transdermal drug delivery.

ProSolus, Inc. Questions

The ProSolus, Inc. annual revenue was $4 million in 2026.

Will Jackson is the Vice President of MFG Operations of ProSolus, Inc..

10 people are employed at ProSolus, Inc..

ProSolus, Inc. is based in Miami, Florida.

The NAICS codes for ProSolus, Inc. are [3254, 325, 32, 32541].

The SIC codes for ProSolus, Inc. are [28, 283].

Top ProSolus, Inc. Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users